As reported for 2025, the Western Europe industry was valued at USD 117.97 billion and showed a YoY growth of 5.0%.
Our analysis projects that, at year-end 2033, the Western Europe Infusion Services Market size will reach USD 252.20 billion, achieving a CAGR of 10.0% through the forecast period.
High oncology prevalence and structured reimbursement frameworks maintain steady infusion volumes, with gradual outpatient decentralization improving system efficiency.
OECD health statistics indicate sustained public healthcare expenditure levels across Western European countries, supporting stable infusion infrastructure investment.
DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation.
[Learn more]